What is sclerotherapy (sclero) with foam for venous insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Foam Sclerotherapy for Venous Insufficiency

Foam sclerotherapy is an effective, minimally invasive treatment option for venous insufficiency that involves injecting a sclerosant agent mixed with air to create foam, which displaces blood and causes endothelial damage, leading to vein closure and symptom relief. 1

What is Foam Sclerotherapy?

Foam sclerotherapy is a technique that transforms liquid sclerosants into foam by mixing them with air, typically using the Tessari technique with a three-way tap. This creates a microfoam that:

  • Displaces blood in the vein rather than mixing with it
  • Increases contact time with the vein wall
  • Provides greater efficacy compared to liquid sclerosants
  • Can be visualized under ultrasound guidance for precise treatment 2, 3

Common Sclerosing Agents

The most commonly used sclerosants for foam preparation include:

  • Sodium tetradecyl sulfate (STS)
  • Polidocanol
  • Hypertonic saline (less commonly) 1, 3

Applications and Indications

Foam sclerotherapy can be used to treat:

  • Varicose veins of various sizes
  • Saphenous trunk incompetence
  • Incompetent perforating veins
  • Venous stasis ulcerations
  • Pelvic venous disorders 1, 2

Procedure Details

  1. Pre-procedure assessment: Confirm absence of significant arterial disease
  2. Ultrasound guidance: Used to target specific veins accurately
  3. Venous access: Obtained percutaneously through varices or targeted veins
  4. Foam preparation: Created using the Tessari technique
  5. Injection: Foam is injected under ultrasound guidance
  6. Post-procedure: Compression therapy (20-30 mmHg) is applied 1, 4, 3

Efficacy and Outcomes

  • Studies show efficacy rivaling traditional surgical ligation and stripping
  • Rapid ulcer healing (2-6 weeks) in cases of chronic venous insufficiency
  • Relief of painful lipodermatosclerosis and dermatitis
  • Some decrease in skin hyperpigmentation
  • Total occlusion rates of 75-98.6% for treated veins 2, 3, 5

Advantages of Foam Sclerotherapy

  • Low cost compared to other interventions
  • Quick patient recovery with minimal downtime
  • No need for analgesics or sedation
  • Outpatient procedure
  • Can be used in combination with other treatments like radiofrequency ablation 2, 3, 6

Potential Complications

Serious complications are rare, but may include:

  • Transient pain (common but self-limiting)
  • Trapped thrombus requiring evacuation
  • Cutaneous staining
  • Deep vein thrombosis (rare, 0.3-1.8%)
  • Transient neurological symptoms (rare)
  • Cutaneous necrosis (very rare) 2, 3

Combined Treatment Approaches

Foam sclerotherapy is often used in combination with other treatments:

  • Can be performed alongside radiofrequency ablation (RFA) in a single session
  • Combined approach may reduce risk of thrombophlebitis in tributaries
  • One-step approach (RFA + foam sclerotherapy) has shown 100% closure of treated truncal veins and 91.7% closure of tributary veins 6

Special Considerations for Pelvic Venous Insufficiency

For pelvic venous disorders:

  • Stop-flow foam sclerotherapy techniques may be used
  • Balloon occlusion of high-outflow collaterals can optimize sclerosant efficacy
  • Studies show significant symptom improvement (approximately 75%) 1

Follow-up Care

  • Compression therapy should be continued for optimal results
  • Follow-up ultrasound within 1-2 weeks to confirm vein closure
  • Some patients may require more than one treatment session 2, 5

Foam sclerotherapy represents an important tool in the modern treatment of venous insufficiency, offering a balance of efficacy, safety, and patient convenience when performed by experienced practitioners.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Foam sclerotherapy for the treatment of superficial venous insufficiency.

The Surgical clinics of North America, 2007

Research

Venous disorders: treatment with sclerosant foam.

The Journal of cardiovascular surgery, 2006

Guideline

Radiofrequency Ablation for Venous Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

One-Step Approach to Treating Venous Insufficiency.

Journal of clinical medicine research, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.